Hikal Ltd. logo

Hikal Ltd. (HIKAL)

Market Closed
10 Aug, 22:00
MSE MSE
223. 95
-1.6
-0.7094%
- Market Cap
- P/E Ratio
2.4% Div Yield
9,382 Volume
- Eps
225.55
Previous Close
Add Transaction
Day Range
221.65 227.05
Year Range
145.95 293
Want to track HIKAL and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

HIKAL closed today lower at ₹223.95, a decrease of -0.7094% from yesterday's close, completing a monthly decrease of -0.1338% or -₹0.3. Over the past 12 months, HIKAL stock lost -1.3436%.
HIKAL pays dividends to its shareholders, with the most recent payment made on Mar 12, 2026. The next estimated payment will be in In 1 month on Sep 12, 2026 for a total of ₹0.2.
The last earnings report, released on May 12, 2026, exceeded the consensus estimates by 0%. On average, the company has fell short of earnings expectations by -0.9435%, based on the last three reports.
Hikal Ltd. has completed 4 stock splits, with the recent split occurring on Jun 22, 2018.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on XNSE (INR).

HIKAL Chart

Hikal Ltd. (HIKAL) FAQ

What is the stock price today?

The current price is ₹223.95.

On which exchange is it traded?

Hikal Ltd. is listed on MSE.

What is its stock symbol?

The ticker symbol is HIKAL.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 2.4%.

What is its market cap?

As of today, no market cap data is available.

Has Hikal Ltd. ever had a stock split?

Hikal Ltd. had 4 splits and the recent split was on Jun 22, 2018.

Hikal Ltd. Profile

Specialty Retail Industry
Consumer Discretionary Sector
- CEO
MSE Exchange
Y3195T157 CUSIP
India Country
2,061 Employees
17 Feb 2026 Last Dividend
22 Jun 2018 Last Split
- IPO Date

Overview

Hikal Limited, along with its subsidiaries, stands as a pivotal manufacturer and seller of a wide range of chemical intermediates, specialty chemicals, and active pharmaceutical ingredients (APIs). The company serves a diverse clientele across the pharmaceutical, animal health, biotech, crop protection, and specialty chemicals sectors. Boasting an extensive international presence, Hikal Limited caters to markets in India, the United States, Canada, Europe, South East Asia, among others. Operating under two main segments, Pharmaceuticals and Crop Protection, the company has shown a commitment to innovation and quality. Pharmaceuticals segment focuses on producing active pharmaceutical ingredients, whereas the Crop Protection segment is dedicated to the manufacturing of pesticides and herbicides. Originally named Hikal Chemical Industries Ltd., it underwent a rebranding to Hikal Limited in April 2000. Since its inception in 1988, Hikal Limited has established its headquarters in Navi Mumbai, India and has continued to expand its global footprint through both direct exports and strategic collaborations.

Products and Services

  • Active Pharmaceutical Ingredients (APIs):

    These are pivotal for the pharmaceutical sector, enabling the creation of a wide array of medicines. Hikal Limited specializes in the production of APIs used in various therapeutics, such as anti-convulsant, anti-emetic, anti-histaminic, anti-depressant, anti-psychotic, anti-lipemic, hemorheologic, anti-diabetic, anti-thrombotic, anti-hypertensive, anti-inflammation, and analgesic drugs.

  • Pesticides and Herbicides:

    Key offerings include diuron tech, temephos tech, thiacloprid tech, clothianidin tech, dichloroaniline, N-bromosuccinimide, prothioconazole technical, trifloxystrobin technical, and BIT. These products are essential for crop protection, aiding in the control of pests and diseases to ensure healthy crop yields.

  • Animal Health Products:

    Hikal offers a range of products for animal health care including anti-tick, anti-parasitic, analgesic, anabolic steroids, female sex hormone, and NSAID products, catering to the well-being of animals.

  • Specialty Biocides and Antimicrobial Actives:

    These substances are designed for use in various industrial applications, including leather, paint coatings, paper, water treatment, personal care, building materials, and textile industries. They play a crucial role in preventing microbial growth and ensuring the durability and safety of products.

  • Contract Research, Custom Synthesis, and Manufacturing:

    In addition to its extensive product portfolio, Hikal Limited offers tailored solutions in contract research, custom synthesis, and custom manufacturing. This involves collaborating with other companies to develop and manufacture intermediates and active ingredients, thus enhancing innovation and meeting specific customer needs.

Contact Information

Address: Great Eastern Chambers
Phone: 91 22 6277 0299